Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Velde, C.J.H. van de
  • (-) = Fontein, D.B.Y.

Search results

  • RSS Feed
(1 - 20 of 27)

Pages

Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)
Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial
Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients - A phase II trial
Physical Activity and Survival of Postmenopausal, Hormone Receptor-Positive Breast Cancer Patients Results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle Study
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial
Relationship between specific adverse events and clinical response to neoadjuvant exemestane therapy in postmenopausal breast cancer patients: Preliminary results from the TEAM IIA trial (BOOG 2004-06)
Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review
Age and the effect of physical activity on breast cancer survival: A systematic review
Symptoms and Cancer Outcome in Adjuvant Endocrine Therapy for Breast Cancer: Why Are They Associated? Reply
Response to: Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy - Recommendations for clinical guidance
Upfront adjuvant aromatase inhibitors in women with lobular breast cancer response
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
Preliminary results of the TEAMIIA trial: Efficacy of six months neoadjuvant exemestane therapy in postmenopausal hormone receptor-positive breast cancer patients - a Dutch Breast Cancer Trialists' Group study
Pre- and postdiagnostic physical activity levels in relation to breast cancer outcome in postmenopausal breast cancer patients - results of the TEAM-lifestyle study
Accuracy of treatment response assessment modalities after neoadjuvant therapy: A Dutch Breast Cancer Trialists' Group (BOOG) substudy
Specific Adverse Events Predict Survival Benefit in Patients Treated With Tamoxifen or Aromatase Inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial Analysis
Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy - Recommendations for clinical guidance
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - A TEAM study analysis

Pages